XSWX
DAE
Market cap3.26bUSD
Jul 09, Last price
154.60CHF
1D
3.07%
1Q
3.76%
Jan 2017
11.71%
Name
Daetwyler Holding AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dätwyler Holding AG, a Pema Holding AG subsidiary established in 1915 and headquartered in Altdorf, Switzerland, specializes in the global manufacture and sale of elastomer components. The company’s products serve a broad spectrum of industries, including healthcare, mobility, oil and gas, and food and beverage, with its market presence spanning Europe, North America, South America, and Asia. Its business operations are structured into two distinct divisions. The Healthcare Solutions segment provides vital rubber parts for items such as pre-filled syringes, injection pens, and drug delivery systems, along with closures for injectable drug vials, and various rubber components essential for blood collection, intravenous administration sets, disposable syringes, diagnostics, and other medical devices. Conversely, the Industrial Solutions segment delivers a range of products including components for electromobility, active assistance and safety systems, brake systems, fuel and engine management solutions, exhaust gas aftertreatment, and diverse sealing elements tailored for upstream applications, power tools, and the water and process industries.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||